Pulmonary effects of inhaled zinc oxide in human subjects, guinea pigs, rats, and rabbits.
Occupational exposure to freshly formed zinc oxide (ZnO) particles (less than 1.0 micron aerodynamic diameter) produces a well-characterized response known as metal fume fever. An 8-hr threshold limit value (TLV) of 5 mg/m3 has been established to prevent adverse health effects because of exposure to ZnO fumes. Because animal toxicity studies have demonstrated pulmonary effects near the current TLV, the present study examined the time course and dose-response of the pulmonary injury produced by inhaled ZnO in guinea pigs, rats, rabbits, and human volunteers. The test animals were exposed to 0, 2.5, or 5.0 mg/m3 ZnO for up to 3 hr and their lungs lavaged. Both the lavage fluid and recovered cells were examined for evidence of inflammation or altered cell function. The lavage fluid from guinea pigs and rats exposed to 5 mg/m3 had significant increases in total cells, lactate dehydrogenase, beta-glucuronidase, and protein content. These changes were greatest 24 hr after exposure. Guinea pig alveolar macrophage function was depressed as evidenced by in vitro phagocytosis of opsonized latex beads. Significant changes in lavage fluid parameters were also observed in guinea pigs and rats exposed to 2.5 mg/m3 ZnO. In contrast, rabbits showed no increase in biochemical or cellular parameters following a 2-hr exposure to 5 mg/m3 ZnO. Differences in total lung burden of ZnO, as determined in additional animals by atomic absorption spectroscopy, appeared to account for the observed differences in species responses. Although the lungs of guinea pigs and rats retained approximately 20% and 12% of the inhaled dose, respectively, rabbits retained only 5%.(ABSTRACT TRUNCATED AT 250 WORDS)
Gordon
T
T
New York University Medical Center, Institute of Environmental Medicine, Tuxedo 10987.
Chen
L C
LC
Fine
J M
JM
Schlesinger
R B
RB
Su
W Y
WY
Kimmel
T A
TA
Amdur
M O
MO
D000818:Animals; D001992:Bronchoalveolar Lavage Fluid / Q000139:chemically induced*; D005334:Fever / Q000139:chemically induced; D006168:Guinea Pigs; D006801:Humans; D008168:Lung / Q000187:drug effects* / Q000201:enzymology; D008171:Lung Diseases / Q000139:chemically induced*; D008297:Male; D008452:Maximum Allowable Concentration; D016273:Occupational Exposure / Q000009:adverse effects*; D011817:Rabbits; D051381:Rats; D012129:Respiratory Function Tests; D012768:Shivering; D015034:Zinc Oxide / Q000009:adverse effects*
D015034:Zinc Oxide